Proinsulin C-Peptide prevents impaired wound healing by activating angiogenesis in diabetes

Journal of Investigative Dermatology

Volumn 135, Issue 1, 2015, Pages 269-278

  Lim, Young Cheol ^a   Bhatt, Mahendra Prasad ^a   Kwon, Mi Hye ^a   Park, Donghyun ^a   Na, Sunghun ^a   Kim, Young Myeong ^a   Ha, Kwon Soo ^a  

^a Kangwon National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ALPHA SMOOTH MUSCLE ACTIN; C PEPTIDE; CD11B ANTIGEN; CD31 ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; WORTMANNIN; WOUND HEALING PROMOTING AGENT;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTINUOUS INFUSION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATORY CELL; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UMBILICAL VEIN ENDOTHELIAL CELL; WOUND CLOSURE; WOUND HEALING IMPAIRMENT; ANIMAL; C57BL MOUSE; CELL MOTION; ENDOTHELIUM CELL; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN ULCER; WOUND HEALING;

ANIMALS; C-PEPTIDE; CELL MOVEMENT; CELL PROLIFERATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; SKIN ULCER; WOUND HEALING;

EID: 84924028057     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.285     Document Type: Article

References (37)

1. Barrientos S, Stojadinovic O, Golinko MS et al. (2008) Growth factors and cytokines in wound healing. Wound Repair Regen 16:585-601
2. Bhatt MP, Lim YC, Hwang J et al. (2013a) C-peptide prevents hyperglycemiainduced endothelial apoptosis through inhibition of reactive oxygen species-mediated transglutaminase 2 activation. Diabetes 62:243-53
3. Bhatt MP, Lim YC, Kim YM et al. (2013b) C-peptide activates AMPKalpha and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes. Diabetes 62:3851-62
4. Caldwell RB, Bartoli M, Behzadian MA et al. (2003) Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives. Diabetes Metab Res Rev 19:442-55
5. Dimmeler S, Fleming I, Fisslthaler B et al. (1999) Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399:601-5
6. Eming SA, Brachvogel B, Odorisio T et al. (2007) Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem 42:115-70
7. Fadini GP, Albiero M, Menegazzo L et al. (2010) The redox enzyme p66Shc contributes to diabetes and ischemia-induced delay in cutaneous wound healing. Diabetes 59:2306-14
8. Ferringer T, Miller F 3rd (2002) Cutaneous manifestations of diabetes mellitus. Dermatol Clin 20:483-92
9. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-70
10. Graves DT, Liu R, Oates TW (2007) Diabetes-enhanced inflammation and apoptosis: impact on periodontal pathosis. Periodontol 2000 45:128-37
11. Hansen SL, Myers CA, Charboneau A et al. (2003) HoxD3 accelerates wound healing in diabetic mice. Am J Pathol 163:2421-31
12. Hills CE, Brunskill NJ, Squires PE (2010) C-peptide as a therapeutic tool in diabetic nephropathy. Am J Nephrol 31:389-97
13. Hirsch T, Spielmann M, Zuhaili B et al. (2008) Enhanced susceptibility to infections in a diabetic wound healing model. BMC Surg 8:5
14. Ido Y, Vindigni A, Chang K et al. (1997) Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277:563-6
15. Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. Lancet 361:1545-51
16. Kitamura T, Kimura K, Jung BD et al. (2002) Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogenactivated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J 366:737-44
17. Kolluru GK, Bir SC, Kevil CG (2012) Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int J Vasc Med 2012:91826
18. Lamalice L, Le Boeuf F, Huot J (2007) Endothelial cell migration during angiogenesis. Circ Res 100:782-94
19. Langer S, Born F, Breidenbach A et al. (2002) Effect of C-peptide on wound healing and microcirculation in diabetic mice. Eur J Med Res 7:502-8
20. Lee SJ, Namkoong S, Kim YM et al. (2006) Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK-and PI3K/Akt/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol 291:H2836-46
21. Li J, Chen J, Kirsner R (2007) Pathophysiology of acute wound healing. Clin Dermatol 25:9-18
22. Lim YC, Bhatt MP, Kwon MH et al. (2013) Prevention of VEGF-mediated microvascular permeability by C-peptide in diabetic mice. Cardiovasc Res 101:155-64
23. Massi-Benedetti M, Orsini-Federici M (2008) Treatment of type 2 diabetes with combined therapy: what are the pros and cons? Diabetes Care 31(Suppl 2):S131-5
24. Min JK, Cho YL, Choi JH et al. (2007) Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood 109:1495-502
25. Monroe DM, Hoffman M (2012) The clotting system-a major player in wound healing. Haemophilia 18(Suppl 5):11-6
26. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC et al. (2005) Health-related quality of life of diabetic foot ulcer patients and their caregivers. Diabetologia 48:1906-10
27. Namkoong S, Kim CK, Cho YL et al. (2009) Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling. Cell Signal 21:906-15
28. Newman AC, Hughes CC (2012) Macrophages and angiogenesis: a role for Wnt signaling. Vasc Cell 4:13
29. Park JY, Jung SH, Jung JW et al. (2009) A novel array-based assay of in situ tissue transglutaminase activity in human umbilical vein endothelial cells. Anal Biochem 394:217-22
30. Sun G, Zhang X, Shen YI et al. (2011) Dextran hydrogel scaffolds enhance angiogenic responses and promote complete skin regeneration during burn wound healing. Proc Natl Acad Sci USA 108:20976-81
31. Wahren J, Ekberg K, Jornvall H (2007) C-peptide is a bioactive peptide. Diabetologia 50:503-9
32. Wahren J, Kallas A, Sima AA (2012) The clinical potential of C-Peptide replacement in type 1 diabetes. Diabetes 61:761-72
33. Wallerath T, Kunt T, Forst T et al. (2003) Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide. Nitric Oxide 9:95-102
34. Werner S, Grose R (2003) Regulation of wound healing by growth factors and cytokines. Physiol Rev 83:835-70
35. Xu F, Zhang C, Graves DT (2013) Abnormal cell responses and role of TNFalpha in impaired diabetic wound healing. Biomed Res Int 2013:75480
36. Yang B, Cao DJ, Sainz I et al. (2004) Different roles of ERK and p38 MAP kinases during tube formation from endothelial cells cultured in 3-dimensional collagen matrices. J Cell Physiol 200:360-9
37. Zhong Z, Davidescu A, Ehren I et al. (2005) C-peptide stimulates ERK1/2 and JNK MAP kinases via activation of protein kinase C in human renal tubular cells. Diabetologia 48:187-97